N/A Completed N=76 Randomized Single-blind Health Services Research

Integrated Physical Training With Protein Diet in Older Adults With Sarcopenia Symptoms.

Sarcopenia

Source: ClinicalTrials.gov NCT05224453 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2022

Primary outcomePrimary: Changes in Hand Grip Strength — 29.2; 29.5; 35.3; 30.3 kg — p=<0.05

Summary

Sarcopenia is the major health concern and common consequence of COVID-19 in the aging population. Moreover, this clinical condition has not been considered in usual physical rehabilitation practice, and its optimal protein requirement in food is not well defined, which requires a meaningful study in this field. The reports of this trial would deliver the latest evidence and proper guidelines for the prescription of physical exercises and also provide an optimal dietary plan in sarcopenia patients with COVID infection. Objective: To find and compare the clinical and psychological effects of integrated physical training with a high protein diet versus a low-protein diet in community-dwelling COVID-19 asymptomatic older adults with Sarcopenia symptoms.

Outcome Measures

Outcome	Result	p-value
PRIMARY Changes in Hand Grip Strength	29.2; 29.5; 35.3; 30.3	<0.05 sig
SECONDARY Change in Muscle Cross Sectional Area	54.9; 55.1; 58.9; 57.2; 65.2; 64.9	<0.05 sig
SECONDARY Changes in Kinesiophobia	32.5; 32.7; 14.2; 22.3	—
SECONDARY Changes in Quality of Life	57.1; 58.0; 68.2; 61.9	—

Eligibility Criteria

Inclusion Criteria

Sarcopenia was diagnosed according to the guidelines given by the Asian working group for Sarcopenia (AWGS).

Appendicular skeletal muscle mass index (ASMI< 7.0 kg/m2) Patients with less muscle mass, Low handgrip strength (< 24 kg) Decrease walking speed (< 0.7 m/sec)

Exclusion Criteria

Subjects with a history of physical workout, Taking medicines Recent surgeries Joint problems in the leg Heart and lung problems Neurological issues Other systemic diseases Contraindications for physical training

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05224453). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.